GSDMC and GSDMD are markedly upregulated in breast cancer and colorectal cancers (Miguchi, et al., 2016; Hou et al., 2020), where they promote tumor cell proliferation and are associated with a worse prognosis (Wang et al., 2019). Here, GSDMD is linked to breast carcinoma.